x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DIA-0243386
| Product Information | |
|---|---|
| CAS No. | 207748-29-6 |
| Synonyms | HMR 1964 |
| Formula | C258H384N64O78S6 |
| Molecular Weight | 5822.57 |
| Target | Insulin Receptor |
| Product Description | Insulin glulisine (HMR 1964) is a rapid-acting insulin analogue, it mimics the pharmacokinetic and pharmacodynamic profiles of physiological human insulin. Insulin glulisine can be used for the research of diabetes. |
| Format & Storage | |
|---|---|
| Format | Liquid |
| Color | Colorless to light yellow |
| Purity | ≥95.0% |
| Shipping | Room temperature in the continental U.S. Other areas may vary. |
| Storage | Store at 4°C, do not freeze |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
